Imaging Analysis Software QyScore Receives FDA Clearance

Imaging Analysis Software QyScore Receives FDA Clearance
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Qynapse‘s QyScore, a software that aids in analyzing brain scans taken by magnetic resonance imaging (MRI). The software, which is compatible with routine imaging workflows, includes an advanced user interface and automatically-generated patient reports. Results are presented in comparison to data on people without known brain disease, giving ... read more
Source: Parkinson’s News TodayPublished on 2020-02-05By Marisa Wexler